triferic
Commercial- Indications
- Iron replacement in hemodialysis, Anemia in hemodialysis patients
Company intelligence / Profile preview
Rockwell Medical manufactures and distributes FDA-regulated hemodialysis concentrates for patients with end-stage kidney disease. The company has a strong reputation for reliability and customer service in the U.S. dialysis market and operates multiple manufacturing facilities across the United States. It recently faced contract losses but remains the second-largest manufacturer of dialysis concentrate in the U.S., with expectations of new contracts to offset recent setbacks. No clinical trial results are relevant as it does not develop drugs.
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rockwell Medical.